Hepatocellular carcinoma p53 G > T transversions at codon 249: The fingerprint of aflatoxin exposure?

Environmental Health Perspectives

Volumn 105, Issue 4, 1997, Pages 392-397

  Lasky, Tamar ^a   Magder, Laurence ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Epidemiology; Gene; Hepatocellular carcinoma; Meta analysis; Molecular epidemiology; Mutation; P53

Indexed keywords

AFLATOXIN; CARCINOGEN;

ARTICLE; CANCER EPIDEMIOLOGY; CODON; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; META ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; RACE; TUMOR SUPPRESSOR GENE;

EID: 0030926083     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.2307/3433335     Document Type: Article

References (48)

1. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327 (1993).
2. Selivanova G, Wiman KG. p53: a cell cycle regulator activated by DNA damage. Adv Cancer Res 66:143-148 (1995).
3. Hollstein M, Sidransky D, Harris BVCC. p53 Mutations in human cancer. Science 253:49-53 (1991).
4. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878 (1994).
5. Bogler O, Huang HJ, Kleihues P, Cavenee WK. The p53 gene and its role in human brain tumors. Glia 15:308-327 (1995).
6. Kastan MB, Canman CE, Leonard CJ. P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14:3-15 (1995).
7. Lee JM, Bernstein A. Apoptosis, cancer and the p53 tumour suppressor gene. Cancer Metastasis Rev 14:149-161 (1995).
8. Gotz C, Montenarh M. p53: DNA damage, DNA repair, and apoptosis. Rev Physiol Biochem Pharmacol 127:65-95 (1996).
9. Ozbun MA, Butel JS. Tumor suppressor p53 mutations and breast cancer: a critical analysis. Adv Cancer Res 66:71-141 (1995).
10. Harris CC. 1995 Deichmann Lecture - p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment. Toxicol Lett 82-83:1-7 (1995).
11. Harris CC. The 1995 Walter Hubert Lecture -molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene. Br J Cancer 73:261-269 (1996).
12. Vogelstein B, Kinzler KW. Carcinogens leave fingerprints [news]. Nature 355:209-210 (1992).
13. Biggs PJ, Warren W, Venitt S, Stratton MR. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis 8:275-283 (1993).
14. Shi CY, Phang TW, Wee A, Ngoi SS, Lin Y, Li B, Ong CN, Lee HP. Mutations of the tumour suppressor gene p53 in colorectal and hepatocellular carcinomas. Ann Acad Med Singapore 24:204-210 (1995).
15. Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338:1356-1359 (1991).
16. Scorsone KA, Zhou YZ, Butel JS, Slagle BL. p53 mutations cluster at codon 249 in hepatitis B vitus-positive hepatocellular carcinomas from China. Cancer Res 52:1635-1638 (1992).
17. Groopman JD, Cain LG, Kensler TW. Aflatoxin exposure in human populations: measurements and relationship to cancer. CRC Crit Rev Toxicol 19:113-145 (1988).
18. Hoogewoud HM. Hepatocellular carcinoma and liver metastases: diagnosis and treatment. Berlin:Springer-Verlag, 1993.
19. IARC. Aflatoxins. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol 56. Some naturally occuring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon:International Agency for Research on Cancer, 1993:245-395.
20. Aguilar F, Hussain SP, Cerutti P. Aflatoxin B1 induces the transversion of G to T in codon 249 of the p53 suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 90:8586-8590 (1993).
21. Challen C, Lunec J, Warren W, Collier J, Bassendine MF. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 16:1362-1366 (1992).
22. Kress S, Jahn UR, Buchmann A, Bannasch P, Schwarz M. p53 mutations in human hepatocellular carcinomas from Germany. Cancer Res 52:3220-3223 (1992).
23. Nose H, Imazeki F, Ohto M, Omata M. p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer 72:355-360 (1993).
24. Volkmann M, Hofmann WJ, Muller M, Rath U, Otto G, Zentgraf H, Galle PR. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene 9:195-204 (1994).
25. Bourdon JC, D'Errico A, Paterlini P, Grigioni W, May E, Debuire B. p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology 108:1176-1182 (1995).
26. De Benedetti VM, Welsh JA, Trivers GE, Harpster A, Parkinson AJ, Lanier AP, McMahon BJ, Bennett WP. p53 is not mutated in hepatocellular carcinomas from Alaska natives. Cancer Epidemiol Biomarkers Prev 4:79-82 (1995).
27. Fujimoto Y. Aberrations of tumor suppressor genes in hepatocellular carcinomas. Hokkaido J Med Sci 69:1252-1260 (1994).
28. Diamantis ID, McGandy C, Chen TJ, Liaw YF, Gudat F, Bianchi L. A new mutational hot-spot in the p53 gene in human hepatocellular carcinoma. J Hepatol 20:553-556 (1994).
29. Ng IO, Srivastava G, Chung LP, Tsang SW, Ng MM. Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer 74:30-37 (1994).
30. Hosono S, Chou MJ, Lee CS, Shih C. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Oncogene 8:491-496 (1993).
31. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H, Ishizaki K. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res 53:368-372 (1993).
32. Zhu MH. Hepatitis B X antigen binding to p53 protein in the pathogenesis of primary hepatocellular carcinoma. Chin Med J 73:325-328 379 (1993).
33. Goldblum JR, Bartos RE, Carr KA, Frank TS. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma. Am J Surg Pathol 17:1244-1251 (1993).
34. Shieh YS, Nguyen C, Vocal MV, Chu HW. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma. Int J Cancer 54:558-562 (1993).
35. Coursaget P, Depril N, Chabaud M, Nandi R, Mayelo V, LeCann P, Yvonnet B. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br J Cancer 67:1395-1397 (1993).
36. Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 14:987-992 (1993).
37. Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R, Sugimachi K. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 53:2884-2887 (1993).
38. Li D, Cao Y, He L, Wang NJ, Gu JR. Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis 14:169-173 (1993).
39. Hollstein MC, Wild CP, Bleicher F, Chutimataewin S, Harris CC, Srivatanakul P, Montesano R. p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Int J Cancer 53:51-55 (1993).
40. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 52:6358-6364 (1992).
41. Buetow KH, Sheffield VC, Zhu M, Zhou T, Shen FM, Hino O, Smith M, McMahon BJ, Lanier AP, London WT, et al. Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas. Proc Natl Acad Sci USA 89:9622-9626 (1992).
42. Sheu JC, Huang GT, Lee PH, Chung JC, Chou HC, Lai MY, Wang JT, Lee HS, Shih LN, Yang PM, et al. Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res 52:6098-6100 (1992).
43. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431 (1991).
44. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428 (1991).
45. Hsu HC, Tseng HJ, Lai PL, Lee PH, Peng SY. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Cancer Res 53:4691-4694 (1993).
46. Cox B, Elwood JM. The effect on the stratum-specific odds ratios of nondifferential misclassification of a dichotomous covariate. Am J Epidemiol 133:202-207 (1991).
47. Wacholder S, Dosemeci M, Lubin JH. Blind assignment of exposure does not always prevent differential misclassification. Am J Epidem 134:433-437 (1991).
48. Hsia CC, Kleiner DE, Jr., Axiotis CA, Di Bisceglie A, Nomura AM, Stemmermann GN, Tabor E. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. J Natl Cancer Inst 84:1638-1641 (1992).